Trojan horse strategies used by pathogens to influence the small ubiquitin-like modifier (SUMO) system of host eukaryotic cells.

PubWeight™: 0.89‹?›

🔗 View Article (PMC 3696380)

Published in J Innate Immun on January 03, 2012

Authors

Miklós Békés1, Marcin Drag

Author Affiliations

1: Department of Biochemistry, New York University School of Medicine, New York, N.Y., USA.

Articles cited by this

Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol (2005) 14.42

Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol (2007) 11.48

Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu Rev Cell Dev Biol (2006) 10.74

Protein modification by SUMO. Annu Rev Biochem (2004) 10.59

SUMO: a history of modification. Mol Cell (2005) 10.40

Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell (1995) 9.27

A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell (1997) 9.01

Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol (2009) 8.85

Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu Rev Biochem (2009) 6.23

A new protease required for cell-cycle progression in yeast. Nature (1999) 5.44

MEROPS: the peptidase database. Nucleic Acids Res (2009) 5.33

Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J Biol Chem (2001) 5.04

The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat Rev Mol Cell Biol (2010) 4.72

Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex. Nature (2005) 4.63

Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J (2001) 4.61

Ubiquitin-like protein involved in the proteasome pathway of Mycobacterium tuberculosis. Science (2008) 4.15

Principles of ubiquitin and SUMO modifications in DNA repair. Nature (2009) 4.10

Something about SUMO inhibits transcription. Curr Opin Genet Dev (2005) 4.05

Modification in reverse: the SUMO proteases. Trends Biochem Sci (2007) 3.84

Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p. J Biol Chem (1997) 3.76

A SUMO ligase is part of a nuclear multiprotein complex that affects DNA repair and chromosomal organization. Proc Natl Acad Sci U S A (2005) 3.62

System-wide changes to SUMO modifications in response to heat shock. Sci Signal (2009) 3.50

Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J (1997) 3.34

The yeast ULP2 (SMT4) gene encodes a novel protease specific for the ubiquitin-like Smt3 protein. Mol Cell Biol (2000) 3.24

SUMOylation and De-SUMOylation: wrestling with life's processes. J Biol Chem (2008) 3.22

SUMOylation regulates kainate-receptor-mediated synaptic transmission. Nature (2007) 2.88

SUMO-targeted ubiquitin ligases in genome stability. EMBO J (2007) 2.77

Conserved function of RNF4 family proteins in eukaryotes: targeting a ubiquitin ligase to SUMOylated proteins. EMBO J (2007) 2.59

Listeria monocytogenes impairs SUMOylation for efficient infection. Nature (2010) 2.57

Structures of the SUMO E1 provide mechanistic insights into SUMO activation and E2 recruitment to E1. EMBO J (2005) 2.54

SUMO-specific proteases: a twist in the tail. Trends Cell Biol (2007) 2.50

Active site remodelling accompanies thioester bond formation in the SUMO E1. Nature (2010) 2.41

The SUMO isopeptidase Ulp2 prevents accumulation of SUMO chains in yeast. J Biol Chem (2003) 2.38

The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15. Mol Cell (2010) 2.32

In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy. Mol Cell Proteomics (2007) 2.30

Site-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif. Mol Cell (2010) 2.10

Structural basis for SENP2 protease interactions with SUMO precursors and conjugated substrates. Nat Struct Mol Biol (2006) 2.07

A SIM-ultaneous role for SUMO and ubiquitin. Trends Biochem Sci (2008) 2.05

The Ulp1 SUMO isopeptidase: distinct domains required for viability, nuclear envelope localization, and substrate specificity. J Cell Biol (2003) 1.97

Xanthomonas type III effector XopD targets SUMO-conjugated proteins in planta. Mol Microbiol (2003) 1.97

A mechanism for inhibiting the SUMO pathway. Mol Cell (2004) 1.93

SUMO protease SENP1 induces isomerization of the scissile peptide bond. Nat Struct Mol Biol (2006) 1.89

A nuclear protease required for flowering-time regulation in Arabidopsis reduces the abundance of SMALL UBIQUITIN-RELATED MODIFIER conjugates. Plant Cell (2003) 1.83

Viral avoidance and exploitation of the ubiquitin system. Nat Cell Biol (2009) 1.77

Ubiquitination, ubiquitin-like modifiers, and deubiquitination in viral infection. Cell Host Microbe (2009) 1.69

N-glycan processing in ER quality control. J Cell Sci (2006) 1.64

XopD SUMO protease affects host transcription, promotes pathogen growth, and delays symptom development in xanthomonas-infected tomato leaves. Plant Cell (2008) 1.62

Small ubiquitin-related modifier (SUMO)-specific proteases: profiling the specificities and activities of human SENPs. J Biol Chem (2007) 1.61

SUMO modification of the ubiquitin-conjugating enzyme E2-25K. Nat Struct Mol Biol (2005) 1.58

Signaling during pathogen infection. Sci STKE (2006) 1.56

Comparative proteomic analysis identifies a role for SUMO in protein quality control. Sci Signal (2011) 1.54

Getting across--bacterial type III effector proteins on their way to the plant cell. EMBO J (2002) 1.53

Two novel type III-secreted proteins of Xanthomonas campestris pv. vesicatoria are encoded within the hrp pathogenicity island. J Bacteriol (2002) 1.53

Emerging roles of the SUMO pathway in mitosis. Cell Div (2008) 1.48

Structural basis of NEDD8 ubiquitin discrimination by the deNEDDylating enzyme NEDP1. EMBO J (2005) 1.48

Structure of the human SENP7 catalytic domain and poly-SUMO deconjugation activities for SENP6 and SENP7. J Biol Chem (2008) 1.47

PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription. Biochem Soc Trans (2007) 1.46

Characterization of the Xanthomonas AvrXv4 effector, a SUMO protease translocated into plant cells. Mol Plant Microbe Interact (2004) 1.42

Viral subversion of apoptotic enzymes: escape from death row. Annu Rev Microbiol (2008) 1.41

Cutting edge: bacterial modulation of epithelial signaling via changes in neddylation of cullin-1. J Immunol (2005) 1.40

DeSUMOylating enzymes--SENPs. IUBMB Life (2008) 1.37

Diversity among xanthomonads pathogenic on pepper and tomato. Annu Rev Phytopathol (1998) 1.34

Viruses and sumoylation: recent highlights. Curr Opin Microbiol (2006) 1.32

Different roles for two ubiquitin-like domains of ISG15 in protein modification. J Biol Chem (2008) 1.31

Chlamydia trachomatis-derived deubiquitinating enzymes in mammalian cells during infection. Mol Microbiol (2006) 1.30

Type III effector proteins from the plant pathogen Xanthomonas and their role in the interaction with the host plant. J Plant Physiol (2005) 1.29

Dop functions as a depupylase in the prokaryotic ubiquitin-like modification pathway. EMBO Rep (2010) 1.27

Formation and nuclear export of preribosomes are functionally linked to the small-ubiquitin-related modifier pathway. Traffic (2006) 1.27

Protection from isopeptidase-mediated deconjugation regulates paralog-selective sumoylation of RanGAP1. Mol Cell (2009) 1.22

Activity profiling of human deSUMOylating enzymes (SENPs) with synthetic substrates suggests an unexpected specificity of two newly characterized members of the family. Biochem J (2008) 1.18

A deneddylase encoded by Epstein-Barr virus promotes viral DNA replication by regulating the activity of cullin-RING ligases. Nat Cell Biol (2010) 1.17

Post-translational modifications in host cells during bacterial infection. FEBS Lett (2010) 1.16

ElaD, a Deubiquitinating protease expressed by E. coli. PLoS One (2007) 1.11

Structural analysis of Xanthomonas XopD provides insights into substrate specificity of ubiquitin-like protein proteases. J Biol Chem (2007) 1.08

The dynamics and mechanism of SUMO chain deconjugation by SUMO-specific proteases. J Biol Chem (2011) 1.06

Evolution of a signalling system that incorporates both redundancy and diversity: Arabidopsis SUMOylation. Biochem J (2006) 1.05

Epstein-barr virus encodes three bona fide ubiquitin-specific proteases. J Virol (2008) 1.01

Viral serine/threonine protein kinases. J Virol (2010) 0.99

Functional characterization of a SUMO deconjugating protease of Plasmodium falciparum using newly identified small molecule inhibitors. Chem Biol (2011) 0.99

Detection and functional characterization of a 215 amino acid N-terminal extension in the Xanthomonas type III effector XopD. PLoS One (2010) 0.95

Serpins and regulation of cell death. Results Probl Cell Differ (1998) 0.93

Acetylation, deacetylation and acyltransfer. Environ Health Perspect (1983) 0.92

Crystal structure of human ISG15 protein in complex with influenza B virus NS1B. J Biol Chem (2011) 0.85

Articles by these authors

Small ubiquitin-related modifier (SUMO)-specific proteases: profiling the specificities and activities of human SENPs. J Biol Chem (2007) 1.61

A constitutively active and uninhibitable caspase-3 zymogen efficiently induces apoptosis. Biochem J (2009) 1.33

Distribution and paralogue specificity of mammalian deSUMOylating enzymes. Biochem J (2010) 1.33

Plasmodium falciparum neutral aminopeptidases: new targets for anti-malarials. Trends Biochem Sci (2009) 1.21

Probing the S1 specificity pocket of the aminopeptidases that generate antigenic peptides. Biochem J (2011) 1.10

Caspase substrates and inhibitors. Cold Spring Harb Perspect Biol (2013) 1.07

Synthetic substrates for measuring activity of autophagy proteases: autophagins (Atg4). Autophagy (2010) 1.03

Fingerprinting the substrate specificity of M1 and M17 aminopeptidases of human malaria, Plasmodium falciparum. PLoS One (2012) 1.00

Functional characterization of a SUMO deconjugating protease of Plasmodium falciparum using newly identified small molecule inhibitors. Chem Biol (2011) 0.99

Activation and specificity of human caspase-10. Biochemistry (2010) 0.98

Mechanism and specificity of the human paracaspase MALT1. Biochem J (2012) 0.96

Metallo-aminopeptidase inhibitors. Biochimie (2010) 0.94

Design of ultrasensitive probes for human neutrophil elastase through hybrid combinatorial substrate library profiling. Proc Natl Acad Sci U S A (2014) 0.93

Small molecules not direct activators of caspases. Nat Chem Biol (2007) 0.92

Structural and functional insights into caseinolytic proteases reveal an unprecedented regulation principle of their catalytic triad. Proc Natl Acad Sci U S A (2013) 0.91

Synthesis and structure-activity relationships of phosphonic arginine mimetics as inhibitors of the M1 and M17 aminopeptidases from Plasmodium falciparum. J Med Chem (2013) 0.91

Chemical target validation studies of aminopeptidase in malaria parasites using alpha-aminoalkylphosphonate and phosphonopeptide inhibitors. Antimicrob Agents Chemother (2008) 0.88

Gingipain aminopeptidase activities in Porphyromonas gingivalis. Biol Chem (2012) 0.88

X-ray crystal structure and specificity of the Plasmodium falciparum malaria aminopeptidase PfM18AAP. J Mol Biol (2012) 0.87

Two-pronged attack: dual inhibition of Plasmodium falciparum M1 and M17 metalloaminopeptidases by a novel series of hydroxamic acid-based inhibitors. J Med Chem (2014) 0.83

The Staphylococcus aureus leucine aminopeptidase is localized to the bacterial cytosol and demonstrates a broad substrate range that extends beyond leucine. Biol Chem (2013) 0.81

Esters of betulin and betulinic acid with amino acids have improved water solubility and are selectively cytotoxic toward cancer cells. Bioorg Med Chem Lett (2009) 0.81

Unnatural amino acids increase activity and specificity of synthetic substrates for human and malarial cathepsin C. Amino Acids (2014) 0.81

S1 pocket fingerprints of human and bacterial methionine aminopeptidases determined using fluorogenic libraries of substrates and phosphorus based inhibitors. Biochimie (2011) 0.80

Recent advances and concepts in substrate specificity determination of proteases using tailored libraries of fluorogenic substrates with unnatural amino acids. Biol Chem (2015) 0.80

Positive correlation between cyclooxygenase-2 and ABC-transporter expression in non-Hodgkin's lymphomas. Oncol Rep (2009) 0.79

Positive correlation between cyclooxygenase 2 and the expression of ABC transporters in non-small cell lung cancer. Anticancer Res (2008) 0.78

Molecular determinants involved in activation of caspase 7. Biosci Rep (2011) 0.78

Activity, specificity, and probe design for the smallpox virus protease K7L. J Biol Chem (2012) 0.77

Substrate specificity screening of oat (Avena sativa) seeds aminopeptidase demonstrate unusually broad tolerance in S1 pocket. Plant Physiol Biochem (2012) 0.77

Identification of the molecular basis of inhibitor selectivity between the human and streptococcal type I methionine aminopeptidases. J Med Chem (2015) 0.76

A remarkable activity of human leukotriene A4 hydrolase (LTA4H) toward unnatural amino acids. Amino Acids (2014) 0.75

Betulinic acid exhibits stronger cytotoxic activity on the normal melanocyte NHEM-neo cell line than on drug-resistant and drug-sensitive MeWo melanoma cell lines. Mol Med Rep (2011) 0.75

Identification of very potent inhibitor of human aminopeptidase N (CD13). Bioorg Med Chem Lett (2010) 0.75

Human 20S proteasome activity towards fluorogenic peptides of various chain lengths. Biol Chem (2016) 0.75

Redox reaction between amino-(3,4-dihydroxyphenyl)methyl phosphonic acid and dopaquinone is responsible for the apparent inhibitory effect on tyrosinase. Eur J Biochem (2002) 0.75